- 专利标题： Heteroaromate OSC inhibitors
-
申请号： US11178164申请日： 2005-07-08
-
公开(公告)号： US20050267200A1公开(公告)日： 2005-12-01
- 发明人: Johannes Aebi , Jean Ackermann , Henrietta Dehmlow , Hans-Peter Maerki , Olivier Morand
- 申请人： Johannes Aebi , Jean Ackermann , Henrietta Dehmlow , Hans-Peter Maerki , Olivier Morand
- 优先权： EP00123826.0 20001102
- 主分类号： A61K31/381
- IPC分类号： A61K31/381 ; A61K31/397 ; A61K31/428 ; A61K31/454 ; A61K31/496 ; A61K31/506 ; A61K31/5377 ; A61P3/00 ; A61P3/06 ; A61P3/10 ; A61P9/00 ; A61P9/10 ; A61P13/12 ; A61P31/10 ; A61P33/00 ; A61P35/00 ; C07D275/04 ; C07D275/06 ; C07D333/54 ; C07D409/12 ; C07D417/12 ; C07D521/00 ; C07D333/72 ; C07D409/02
摘要：
The present invention relates to heteroaromate OSC inhibitors. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
公开/授权文献
- US07173043B2 Heteroaromate OSC inhibitors 公开/授权日：2007-02-06
信息查询
